IS ST. JUDE MEDICAL A TAKEOVER TARGET?

Boston Scientific Corp.'s $25 billion bid to buy cardiac-defibrillator maker Guidant Corp. is fanning speculation that rival St. Jude Medical Inc. could be the next hot takeover property. Shares of St. Jude jumped nearly 5% Monday, following news that Boston Scientific has offered to acquire Guidant for $72 a share, a move that could trump Johnson & Johnson's bid of $63.43 a share.

MarketWatch (http://www.marketwatch.com/news/story.asp?guid=%7BB7AA4314-63BA-4654-973D-D77A894848B7%7D&siteid=google&dist=)